The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Glossary Glossary

Tivicay (Dolutegravir)

The Details

Tivicay (dolutegravir or DTG) is an integrase inhibitor used to treat HIV/AIDS. It is approved by the U.S. FDA for the treatment of HIV infection in adults and children 12 years of age and older and weighing at least 88 pounds. It is listed in the HHS HIV treatment guidelines as part of a recommended regimen for people starting HIV treatment for the first time, when taken in combination with Epzicom or Truvada.


Adult single dose: Take one 50-mg tablet once daily.


  • Take Tivicay by mouth, with or without food.
  • Take Tivicay 2 hours before or 6 hours after taking cation-containing antacids or laxatives, sucralfate, oral iron supplements, oral calcium supplements, or buffered medications.
  • Do not take Tivicay if you take dofetilide.
  • Women should not breastfeed while on Tivicay.
The Basics

  • Email Email
  • Glossary Glossary

The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.